Mario Schlosser Sells 150,000 Shares of Oscar Health (NYSE:OSCR) Stock

Posted by Brenda Bartman on Aug 31st, 2026

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) Director Mario Schlosser sold 150,000 shares of the stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $30.79, for a total value of $4,618,500.00. Following the sale, the director owned 480,866 shares of the company’s stock, valued at $14,805,864.14. This represents a 23.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Mario Schlosser also recently made the following trade(s):

On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00.
On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00.
On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total transaction of $25,854,400.00.
On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80.

Oscar Health Price Performance

Shares of OSCR stock traded down $0.47 during mid-day trading on Monday, hitting $30.00. The company had a trading volume of 3,638,656 shares, compared to its average volume of 7,137,195. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $33.55. The stock’s 50 day moving average price is $30.27 and its 200-day moving average price is $22.13. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The company has a market capitalization of $9.26 billion, a P/E ratio of 21.43, a P/E/G ratio of 0.63 and a beta of 2.36.

Oscar Health (NYSE:OSCR – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. Oscar Health’s quarterly revenue was up 70.4% on a year-over-year basis. During the same period last year, the company posted ($0.89) earnings per share. Equities research analysts forecast that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. GAMMA Investing LLC grew its stake in Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after purchasing an additional 357 shares in the last quarter. Focus Partners Wealth raised its position in Oscar Health by 1.4% during the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares in the last quarter. Equitable Holdings Inc. lifted its holdings in shares of Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock worth $186,000 after buying an additional 850 shares during the period. Captrust Financial Advisors lifted its holdings in shares of Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock worth $657,000 after buying an additional 895 shares during the period. Finally, O Shaughnessy Asset Management LLC grew its position in shares of Oscar Health by 5.6% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock worth $255,000 after buying an additional 938 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

OSCR has been the topic of several research reports. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a report on Tuesday, July 28th. The Goldman Sachs Group reissued a “neutral” rating and set a $30.00 price target on shares of Oscar Health in a research note on Tuesday, August 11th. Robert W. Baird set a $27.00 price target on Oscar Health in a report on Friday, August 7th. Weiss Ratings raised Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Finally, Barclays increased their target price on Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $26.22.

Get Our Latest Stock Report on OSCR

About Oscar Health

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.